Nipradilol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263128This classification denotes a beta-adrenergic blocking agent with the molecular formula C15H22N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FVM336I71Y, chemically known as 3,4-dihydro-8-(2-hydroxy-3-isopropylamino)propoxy-3-nitroxy-2h-1-benzopyran but generally known as nipradilol, which bears US NIH Compound Identifier 72006. European Medicines Agency schedules Nipradilol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12423MIG. The term NIPRADILOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). NIPRADILOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nipradilol under HS 29329985 and SITC 51569. As of Q4 2014, NIPRADILOL remains the US FDA Preferred Term for this commodity. Nipradilol bears US NLM identifiers UMLS ID C0132531 and NCI Concept Code C76555. SMILES: O1CC(O[N](=O)O)CC2C1C(OCC(O)CNC(C)C)CCC2.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.